Published in Pediatr Infect Dis J on October 01, 1991
Nutritionally mediated programming of the developing immune system. Adv Nutr (2011) 1.16
Evaluation of the immunogenicity and safety of an indigenously developed DTwP-Hib tetravalent combination vaccine (Shan 4) with EasyFourTM in Indian infants administered per EPI schedule: a phase III trial. Hum Vaccin (2010) 0.84
Can Haemophilus influenzae type b-tetanus toxoid conjugate vaccine be combined with diphtheria toxoid-pertussis vaccine-tetanus toxoid? CMAJ (1993) 0.83
Combined diphtheria, tetanus, pertussis, and Haemophilus influenzae type b vaccines for primary immunisation. Arch Dis Child (1996) 0.83
A randomized, open-label clinical trial to evaluate Immunogenicity and Safety of an indigenously developed DTwP-Hib Tetravalent Combination Vaccine (Easyfour®-TT) with Quadrovax® in Indian infants. Hum Vaccin Immunother (2017) 0.75
Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen Psychiatry (2001) 4.70
Febrile infants at low risk for serious bacterial infection--an appraisal of the Rochester criteria and implications for management. Febrile Infant Collaborative Study Group. Pediatrics (1994) 3.38
High prevalence of Kingella kingae in joint fluid from children with septic arthritis revealed by the BACTEC blood culture system. J Clin Microbiol (1992) 2.98
Evaluation of a medium (STGG) for transport and optimal recovery of Streptococcus pneumoniae from nasopharyngeal secretions collected during field studies. J Clin Microbiol (2001) 2.92
Prolonged atypical illness associated with serological evidence of persistent Epstein-Barr virus infection. Lancet (1982) 2.34
Serogroup-specific epidemiology of Streptococcus pneumoniae: associations with age, sex, and geography in 7,000 episodes of invasive disease. Clin Infect Dis (1996) 2.29
Potential interventions for the prevention of childhood pneumonia: geographic and temporal differences in serotype and serogroup distribution of sterile site pneumococcal isolates from children--implications for vaccine strategies. Pediatr Infect Dis J (1995) 2.00
Identification and characterization of a novel family of pneumococcal proteins that are protective against sepsis. Infect Immun (2001) 1.97
Lack of utility of serotyping multiple colonies for detection of simultaneous nasopharyngeal carriage of different pneumococcal serotypes. Pediatr Infect Dis J (2000) 1.87
Identification of infants unlikely to have serious bacterial infection although hospitalized for suspected sepsis. J Pediatr (1985) 1.73
Use of fluoroquinolones in pediatrics: consensus report of an International Society of Chemotherapy commission. Pediatr Infect Dis J (1995) 1.70
Poliomyelitis outbreak in Israel in 1988: a report with two commentaries. Lancet (1990) 1.67
Combined vaccination of Haemophilus influenzae type b conjugate and diphtheria-tetanus-pertussis containing acellular pertussis. Lancet (1999) 1.65
Oral ciprofloxacin vs. intramuscular ceftriaxone as empiric treatment of acute invasive diarrhea in children. Pediatr Infect Dis J (2000) 1.58
An outbreak of Streptococcus pneumoniae serotype 1 in a closed community in southern Israel. Clin Infect Dis (2000) 1.57
Diagnosis of enterovirus infection by polymerase chain reaction of multiple specimen types. Pediatr Infect Dis J (1997) 1.52
Glycolytic enzymes associated with the cell surface of Streptococcus pneumoniae are antigenic in humans and elicit protective immune responses in the mouse. Clin Exp Immunol (2004) 1.47
Interference of antibody production to hepatitis B surface antigen in a combination hepatitis A/hepatitis B vaccine. J Infect Dis (1999) 1.45
Kingella kingae: an emerging cause of invasive infections in young children. Clin Infect Dis (1997) 1.44
Medical management of chronic suppurative otitis media without cholesteatoma in children. J Pediatr (1990) 1.43
Acquisition, carriage, and transmission of pneumococci with decreased antibiotic susceptibility in young children attending a day care facility in southern Israel. J Infect Dis (1998) 1.42
High prevalence of "Simkania Z," a novel Chlamydia-like bacterium, in infants with acute bronchiolitis. J Infect Dis (1998) 1.38
A combination of four cell types for rapid detection of enteroviruses in clinical specimens. J Med Virol (1986) 1.36
Prevalence of intestinal infections caused by diarrheagenic Escherichia coli in Bedouin infants and young children in Southern Israel. Pediatr Infect Dis J (1998) 1.31
Needle length and injection technique for efficient intramuscular vaccine delivery in infants and children evaluated through an ultrasonographic determination of subcutaneous and muscle layer thickness. Pediatrics (1997) 1.30
Hepatitis and jaundice associated with measles in young adults. An analysis of 65 cases. Arch Intern Med (1983) 1.30
Calves as a source of an outbreak of cryptosporidiosis among young children in an agricultural closed community. Pediatr Infect Dis J (1991) 1.29
Illness, cytokines, and depression. Ann N Y Acad Sci (2000) 1.27
Hospitalizations for infectious diseases in Jewish and Bedouin children in southern Israel. Eur J Epidemiol (1998) 1.27
Respiratory carriage of Kingella kingae among healthy children. Pediatr Infect Dis J (1995) 1.26
Extent of measles hepatitis in various ages. Hepatology (1988) 1.21
A comparison of multiple regimens of pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine and pneumococcal polysaccharide vaccine in toddlers. Vaccine (2000) 1.20
Cytokines, "depression due to a general medical condition," and antidepressant drugs. Adv Exp Med Biol (1999) 1.20
In vitro correlates of cell-mediated immunity in human tonsils after natural or induced Rubella virus infection. J Infect Dis (1975) 1.20
Strain-specific local and systemic cell-mediated immune responses to cytomegalovirus in humans. Infect Immun (1978) 1.18
Antibody response to a two-dose regimen of influenza vaccine in allogeneic T cell-depleted and autologous BMT recipients. Bone Marrow Transplant (1993) 1.17
Alterations in the human immune response to the hepatitis B vaccine among the elderly. Cell Immunol (1987) 1.17
Respiratory syncytial virus infection of human mononuclear leukocytes in vitro and in vivo. J Infect Dis (1985) 1.16
Avidity and subclasses of IgG after immunization of infants with an 11-valent pneumococcal conjugate vaccine with or without aluminum adjuvant. J Infect Dis (2001) 1.16
Detection and treatment of brucellosis by screening a population at risk. Pediatr Infect Dis J (1991) 1.15
Virulence of Streptococcus pneumoniae may be determined independently of capsular polysaccharide. FEMS Microbiol Lett (2004) 1.14
Dynamic of pneumococcal nasopharyngeal carriage in children with acute otitis media following PCV7 introduction in France. Vaccine (2009) 1.14
A decade (1989-1998) of pediatric invasive pneumococcal disease in 2 populations residing in 1 geographic location: implications for vaccine choice. Clin Infect Dis (2001) 1.13
Immunogenicity and safety of a 23-valent pneumococcal polysaccharide vaccine in healthy children and in children at increased risk of pneumococcal infection. Vaccine (1995) 1.12
Randomized comparison of meropenem with cefotaxime for treatment of bacterial meningitis. Meropenem Meningitis Study Group. Antimicrob Agents Chemother (1995) 1.12
Vaccination by non-parenteral routes: characteristics of immune response. Dev Biol Stand (1976) 1.09
The velopharyngeal muscles in speech. An electromyographic and cinéradiographic study. Acta Otolaryngol (1969) 1.09
Prevalence of antimicrobial-resistant pathogens in middle ear fluid: multinational study of 917 children with acute otitis media. Antimicrob Agents Chemother (1998) 1.09
Sex differences in the humoral antibody response to live measles vaccine in young adults. Int J Epidemiol (1994) 1.08
Safety and immunogenicity of Shigella sonnei and Shigella flexneri 2a O-specific polysaccharide conjugates in children. J Infect Dis (1999) 1.07
Severe diffuse adenovirus 7a pneumonia in a child with combined immunodeficiency: possible therapeutic effect of human immune serum globulin containing specific neutralizing antibody. Pediatr Infect Dis (1984) 1.05
Haemophilus influenzae serotype b conjugate vaccine failure in twelve countries with established national childhood immunization programmes. Clin Microbiol Infect (2009) 1.05
Perceptual and acoustic correlates of abnormal voice qualities. Acta Otolaryngol (1981) 1.04
The bacteriology of the nasopharynx in childhood. Int J Pediatr Otorhinolaryngol (1999) 1.04
Resistance pattern of middle ear fluid isolates in acute otitis media recently treated with antibiotics. Pediatr Infect Dis J (1998) 1.04
Virus-specific IgA in serum, saliva, and tears of children with measles. Clin Exp Immunol (1989) 1.03
Persistence of two invasive Streptococcus pneumoniae clones of serotypes 1 and 5 in comparison to that of multiple clones of serotypes 6B and 23F among children in southern Israel. J Clin Microbiol (2001) 1.03
Hepatitis-B vaccination in the elderly. J Infect Dis (1984) 1.03
Safety and immunogenicity of MF59-adjuvanted influenza vaccine in the elderly. Vaccine (1999) 1.03
Thrombocytopenic purpura after measles, mumps and rubella vaccination: a retrospective survey by the French regional pharmacovigilance centres and pasteur-mérieux sérums et vaccins. Pediatr Infect Dis J (1996) 1.02
Echovirus type 22 outbreak associated with gastro-intestinal disease in a neonatal intensive care unit. Am J Perinatol (1997) 1.02
Differential activation of the immune system by virulent Streptococcus pneumoniae strains determines recovery or death of the host. Clin Exp Immunol (2003) 1.02
Natural history of Giardia lamblia and Cryptosporidium infections in a cohort of Israeli Bedouin infants: a study of a population in transition. Am J Trop Med Hyg (1997) 1.01
Giardia lamblia carriage in Israeli Bedouin infants: risk factors and consequences. Clin Infect Dis (2000) 1.01
Successful control of an Acinetobacter baumannii outbreak in a neonatal intensive care unit. J Hosp Infect (2003) 1.00
Fine-needle bone biopsy to diagnose osteomyelitis. J Bone Joint Surg Br (1994) 1.00
Impact of osmolality on burning sensations during and immediately after intramuscular injection of 0.5 ml of vaccine suspensions in healthy adults. Vaccine (2001) 1.00
Infections in hypothermic infants younger than 3 months old. Am J Dis Child (1984) 1.00
Estimating the direct impact of new conjugate vaccines against invasive pneumococcal disease. Vaccine (2009) 0.99
Chronic suppurative otitis media without cholesteatoma in children in southern Israel: incidence and risk factors. Pediatr Infect Dis J (1991) 0.99
Evaluation of the efficacy of a low-passage bovine rotavirus (strain WC3) vaccine in children in Central Africa. Res Virol (1992) 0.98
Marked differences in pneumococcal carriage and resistance patterns between day care centers located within a small area. Clin Infect Dis (1999) 0.98
The immunogenicity and safety of a new combined diphtheria, tetanus and poliomyelitis booster vaccine (Td-eIPV). Infection (1999) 0.98
Prevalence of antibodies to enteroviruses and varicella-zoster virus among residents and overseas volunteers at agricultural settlements in Israel. J Med Virol (1986) 0.97
Population-based study of invasive Kingella kingae infections. Emerg Infect Dis (2000) 0.96
Clinical features and epidemiology of invasive Kingella kingae infections in southern Israel. Pediatrics (1993) 0.96
Prevalence of pilus-encoding islets among acute otitis media Streptococcus pneumoniae isolates from Israel. Clin Microbiol Infect (2010) 0.96
Person-to-person transmission of Kingella kingae among day care center attendees. J Infect Dis (1998) 0.96
Epidemiology, etiology, and clinical features of septic arthritis in children younger than 24 months. Arch Pediatr Adolesc Med (1995) 0.95
Maternal immunization with Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine in The Gambia. JAMA (1996) 0.95
Rapid reduction in invasive pneumococcal disease after introduction of PCV7 into the National Immunization Plan in Israel. Vaccine (2012) 0.95
Focal encephalitis with enterovirus infections. Pediatrics (1991) 0.94
Aerobic bacteriology of chronic suppurative otitis media without cholesteatoma in children. Ann Otol Rhinol Laryngol (1992) 0.94
Nasopharyngeal carriage of multidrug-resistant Streptococcus pneumoniae in institutionalized HIV-infected and HIV-negative children in northeastern Romania. Int J Infect Dis (1999) 0.94
Failure of ceftriaxone in the treatment of acute brucellosis. Clin Infect Dis (1992) 0.94
Beta-lactamase production by Kingella kingae in Israel is clonal and common in carriage organisms but rare among invasive strains. Eur J Clin Microbiol Infect Dis (2013) 0.94
Age-dependent preference in human antibody responses to Streptococcus pneumoniae polypeptide antigens. Clin Exp Immunol (2002) 0.93
Predictive value of pneumococcal nasopharyngeal cultures for the assessment of nonresponsive acute otitis media in children. Pediatr Infect Dis J (2000) 0.93
Differences in the epidemiology of childhood community-acquired bacterial meningitis between two ethnic populations cohabiting in one geographic area. Pediatr Infect Dis J (1988) 0.92
A prospective study of neonatal sepsis and meningitis in southern Israel. Pediatr Infect Dis J (1997) 0.92
Postanginal sepsis following infectious mononucleosis. Arch Intern Med (1987) 0.92
Failure of influenza vaccination in the aged. J Med Virol (1988) 0.92
Increased (2'-5')-oligo-A synthetase activity in patients with prolonged illness associated with serological evidence of persistent Epstein-Barr virus infection. Lancet (1982) 0.92
Viral antibodies in agricultural populations exposed to aerosols from wastewater irrigation during a viral disease outbreak. Am J Epidemiol (1987) 0.92
Early severe dehydration in young breast-fed newborn infants. Isr J Med Sci (1993) 0.92
Pseudooutbreak of Candida guilliermondii fungemia in a neonatal intensive care unit. Pediatr Infect Dis J (1991) 0.91
Cryptosporidium infection in Bedouin infants assessed by prospective evaluation of anticryptosporidial antibodies and stool examination. Am J Epidemiol (2001) 0.91
The isolation of enteroviruses from blood: a comparison of four processing methods. J Med Virol (1984) 0.91
Tolerability and immunogenicity of an eleven-valent pneumococcal conjugate vaccine in healthy toddlers. Pediatr Infect Dis J (2001) 0.90